This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Competitive Technologies, Inc.'s Calmare(R) Pain Therapy Medical Device In The News

FAIRFIELD, Conn., Feb. 15, 2013 (GLOBE NEWSWIRE) -- Competitive Technologies, Inc. (OTCQX:CTTC) announced today that Johns Hopkins pain specialist Paul J. Christo, MD, MBA, will discuss CTTC's Calmare ® medical device featuring the "Scrambler Therapy" ® system on his radio talk show on pain and pain relief, "Aches and Gains." The program scheduled to air on Saturday, February 16, 2013 at 8 p.m. Eastern time on WBAL Radio (1090 AM, Baltimore, MD) will be available online and via podcast for those unable to listen live at: www.paulchristomd.com

"Competitive Technologies is pleased to announce this public discussion of our Calmare ® device as an effective treatment for patients suffering from intractable chronic pain resistant to pharmaceutical treatments, traditional TENS, and surgically implanted devices," said CEO Carl O'Connell.  "Calmare is a non-invasive treatment, with no known side effects, that provides pain relief for many difficult conditions where the patient has exhausted all forms of standard treatment. 

"We are pleased to have renowned pain specialist Dr. Christo feature our pain treatment prominently on his program," Mr. O'Connell continued. "We believe it affirms the efficacy of our device and its potential in the market for pain relief."

About Dr. Paul Christo

Dr. Christo is one of America's foremost experts on relieving pain.  He and a team of specialists help patients overcome the agony of back pain, cancer pain, persistent shingles pain, surgery, thoracic outlet syndrome, and a wide variety of other conditions.

Dr. Christo is a board certified, Harvard-trained anesthesiologist and Hopkins-trained pain medicine specialist. He lectures internationally, serves on editorial boards, teaches, co-edited 3 textbooks on pain, and has published over 60 articles and book chapters on many topics related to pain treatment.  Dr. Christo hosts "Aches and Gains," a talk show on pain and pain relief that airs weekly on WBAL Radio, 1090 AM.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,162.99 +121.45 0.67%
S&P 500 2,123.48 +19.28 0.92%
NASDAQ 5,106.5930 +73.8420 1.47%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs